ArticleEuropean journal of medical research2023

Pan-cancer analysis identifies RNF43 as a prognostic, therapeutic and immunological biomarker.

Yingting Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.